Sunday, April 12, 2026

Week in Review 15/26



 

Welcome and thanks for reading!

In this review, I will make a summary of important and interesting news and events over the last week related to my portfolio holdings. Also, I will put together some interesting articles from other websites that caught my attention during the past week.



Received Dividends:



April 7, 2026


  • €149.00 – Neste Corporation (NESTE)
  • €101.36 – Canadian Natural Resources Limited (CNQ)
  • €41.13 – JPM Global Equity Premium Income Active UCITS ETF (JGPI.DE)
  • €15.14 – JPM US Equity Premium Income Active UCITS ETF (JEIP.DE)
  • €57.41 – JPM Nasdaq Equity Premium Income Active UCITS ETF (JEQP.DE)


April 8, 2026


  • €68.54 – Kesko Corporation (KESKO)


April 9, 2026


  • €20.53 – Illinois Tool Works Inc. (ITW)


Week 15: Total net dividends €453.12


Dividend income is reported after the deduction of taxes. Check more at my Monthly Dividend sheet.



My Portfolio's Transactions:



April 10, 2026


  • I trimmed my position in Eaton Corporation plc (ETN), selling 10 shares at $406.02 per share. At current exchange rates, this will reduce my expected annual net dividend income by approximately €27.96.



Portfolio Holdings News:



April 6, 2026


  • AbbVie Inc. (ABBV) lowers Q1 and FY 2026 earnings outlook following $744M R&D charge; ABBV announced that its first-quarter 2026 reported GAAP and adjusted non-GAAP earnings are expected to include acquired IPR&D and milestone expenses of $744 million on a pre-tax basis, negatively impacting both GAAP and adjusted diluted EPS by $0.41. The company lowered its full-year 2026 adjusted diluted EPS guidance to $13.96–$14.16 from $14.37–$14.57. First-quarter guidance was also reduced to $2.56–$2.60 from $2.97–$3.01.


  • Raytheon, a business unit of RTX Corporation (RTX), has been awarded an undefinitized, not-to-exceed contract valued at approximately $708.94 million for Small Diameter Bomb Increment II Lot 12. The scope includes production, containers, test equipment, and spare components.


April 7, 2026


  • Gilead Sciences, Inc. (GILD) to Acquire Tubulis GmbH; GILD has entered into a definitive agreement to acquire Tubulis GmbH, a privately held, Germany-based clinical-stage biotechnology company focused on next-generation antibody-drug conjugates (ADCs), enhancing its oncology pipeline in areas of high unmet need. The transaction includes an upfront cash payment of $3.15 billion, along with up to $1.85 billion in contingent milestone payments. The acquisition is expected to close in the second quarter of 2026.




April 8, 2026


  • Lockheed Martin Services, a subsidiary of Lockheed Martin Corporation (LMT), won a $105M firm-fixed-price task order to support GPS IIIF launch and on-orbit testing operations.



April 9, 2026



  • Lockheed Martin Corporation (LMT) was awarded a $4.76B firm-fixed-price contract for the production of PAC-3 Missile Segment Enhancement missiles, including all incidental services, hardware, equipment, technical planning, management, and manufacturing efforts.




Articles that caught my attention:





Thanks for stopping by!


No comments:

Post a Comment